1. Home
  2. Stocks
  3. Camlinfine Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Camlin Fine Sciences Share Price

    Small Cap
    ₹102.03
    + 1.61 (1.6%)
    05 October, 2024 00:17 BSE: 532834 NSE: CAMLINFINE ISIN: INE052I01032

    Start SIP in Camlin Fine Sciences

    Start SIP

    Camlin Fine Sciences Performance

    Day Range

    • Low 99
    • High 104
    ₹ 102

    52 Week Range

    • Low 80
    • High 169
    ₹ 102
    • Open Price101
    • Previous Close100
    • Volume675144

    Camlin Fine Sciences Chart

    • Over 1 Month -1.92%
    • Over 3 Month -0.94%
    • Over 6 Month + 1.32%
    • Over 1 Year -37.27%

    Camlin Fine Sciences Key Statistics

    P/E Ratio -12
    PEG Ratio 0
    Market Cap Cr 1,709
    Price to Book Ratio 2.1
    EPS -2.9
    Dividend 0
    Relative Strength Index 42.77
    Money Flow Index 48.52
    MACD Signal -0.86
    Average True Range 3.7

    Camlin Fine Sciences Investment Rating

    • Master Rating:

    • Camlin Fine Sciences has an operating revenue of Rs. 1,589.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of -6% needs improvement, ROE of -11% is poor and needs improvement. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Camlin Fine Sciences Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 182220186206161218
    Operating Expenses Qtr Cr 175246180185136184
    Operating Profit Qtr Cr 7-266212534
    Depreciation Qtr Cr 131312121211
    Interest Qtr Cr 141413151213
    Tax Qtr Cr -4-5-6114
    Net Profit Qtr Cr -14-44-12-168
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 792818
    Operating Expenses Annual Cr 746662
    Operating Profit Annual in Cr 27128
    Depreciation Cr 4933
    Interest Annual Cr 5457
    Tax Annual Cr -819
    Net Profit Annual Cr -5148
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 8219
    Cash from Investing Activity Annual Cr -52-115
    Cash from Financing Annual Activity Cr -3478
    Net Cash Flow Annual Cr -4-18
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 712639
    Fixed Assets Annual Cr 608611
    Total Non Current Assets Annual Cr 711718
    Total Current Assets Annual Cr 861876
    Total Assets Annual Cr 1,5721,594
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 4341
    ROE Annual % -77
    ROCE Annual % 013
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 620
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 396402386406420427
    Operating Expenses Qtr Cr 378415363381381383
    Operating Profit Qtr Cr 18-1323253944
    Depreciation Qtr Cr 202021191918
    Interest Qtr Cr 231614201010
    Tax Qtr Cr 11-125945
    Net Profit Qtr Cr -34-77-12-19169
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,6291,687
    Operating Expenses Annual Cr 1,5391,476
    Operating Profit Annual in Cr 74205
    Depreciation Cr 7963
    Interest Annual Cr 6059
    Tax Annual Cr 641
    Net Profit Annual Cr -9352
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 13951
    Cash from Investing Activity Annual Cr -66-125
    Cash from Financing Annual Activity Cr -8660
    Net Cash Flow Annual Cr -13-14
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 861816
    Fixed Assets Annual Cr 815848
    Total Non Current Assets Annual Cr 951972
    Total Current Assets Annual Cr 1,0011,088
    Total Assets Annual Cr 1,9522,060
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5152
    ROE Annual % -117
    ROCE Annual % 112
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 613
    Invest in Camlin Fine Sciences

    Camlin Fine Sciences Technicals

    EMA & SMA

    Current Price
    ₹102.03
    + 1.61 (1.6%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹104.41
    • 50 Day
    • ₹105.81
    • 100 Day
    • ₹107.36
    • 200 Day
    • ₹113.77
    • 20 Day
    • ₹105.25
    • 50 Day
    • ₹107.34
    • 100 Day
    • ₹105.34
    • 200 Day
    • ₹111.32

    Camlin Fine Sciences Resistance and Support

    PIVOT
    ₹101.8
    Resistance
    First Resistance 104.47
    Second Resistance 106.91
    Third Resistance 109.58
    RSI 42.77
    MFI 48.52
    MACD Single Line -0.86
    MACD -1.29
    Support
    First Support 99.36
    Second Support 96.69
    Third Supoort 94.25

    Camlin Fine Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 870,286 37,352,675 42.92
    Week 565,305 27,892,149 49.34
    1 Month 703,907 32,949,869 46.81
    6 Month 1,104,419 45,369,515 41.08

    Camlin Fine Sciences Result Highlights

    Camlin Fine Sciences Synopsis

    NSE-Chemicals-Specialty

    Camlin Fine Sciences is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 773.26 Cr. and Equity Capital is Rs. 16.75 Cr. for the Year ended 31/03/2024. Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361.
    Market Cap 1,682
    Sales 794
    Shares in Float 8.71
    No of funds 44
    Yield 0.47
    Book Value 2.36
    U/D Vol ratio 1.3
    LTDebt / Equity 31
    Alpha -0.31
    Beta 1.24

    Camlin Fine Sciences Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 48.02%48.03%48.03%48.03%
    Mutual Funds 4.41%2.77%2.75%2.74%
    Foreign Portfolio Investors 1.01%1.69%0.99%1.61%
    Financial Institutions/ Banks 0.94%
    Individual Investors 33.89%32.75%34.18%33.23%
    Others 12.67%13.82%14.05%14.39%

    Camlin Fine Sciences Management

    Name Designation
    Mr. Ashish Dandekar Chairman & Managing Director
    Mr. Nirmal Momaya Managing Director
    Mr. Arjun Dukane Executive Director -Technical
    Mr. Mahabaleshwar Palekar Independent Director
    Mr. Pradip Kanakia Independent Director
    Mr. Amol Shah Independent Director
    Mr. Sutapa Banerjee Independent Director
    Mr. Joseph Conrad D'souza Independent Director
    Ms. Anagha Dandekar Non Exe.Non Ind.Director
    Mr. Harsha Raghavan Non Exe.Non Ind.Director

    Camlin Fine Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Camlin Fine Sciences Corporate Action

    Date Purpose Remarks
    2024-08-12 Quarterly Results
    2024-05-20 Audited Results
    2024-02-09 Quarterly Results
    2023-11-06 Quarterly Results
    2023-08-11 Quarterly Results

    Camlin Fine Sciences MF Shareholding

    Name Amount(cr)
    ICICI Prudential Smallcap Fund Growth 8,731
    ICICI Prudential Dividend Yield Equity Fund Growth 4,841
    ICICI Prudential Commodities Fund Regular Growth 2,557
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 1,487
    ICICI Prudential Retirement Fund Pure Equity Plan Regular Growth 980

    Camlin Fine Sciences FAQs

    What is Share Price of Camlin Fine Sciences ?

    Camlin Fine Sciences share price is ₹102 As on 05 October, 2024 | 00:03

    What is the Market Cap of Camlin Fine Sciences ?

    The Market Cap of Camlin Fine Sciences is ₹1709 Cr As on 05 October, 2024 | 00:03

    What is the P/E ratio of Camlin Fine Sciences ?

    The P/E ratio of Camlin Fine Sciences is -12 As on 05 October, 2024 | 00:03

    What is the PB ratio of Camlin Fine Sciences ?

    The PB ratio of Camlin Fine Sciences is 2.1 As on 05 October, 2024 | 00:03

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.